Ribomic Inc
TSE:4591
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Reliance Chemotex Industries Ltd
NSE:RELCHEMQ
|
IN |
|
Holmen AB
STO:HOLM B
|
SE |
Ribomic Inc
PP&E Net
Ribomic Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ribomic Inc
TSE:4591
|
PP&E Net
¥6m
|
CAGR 3-Years
125%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-9%
|
|
|
SanBio Co Ltd
TSE:4592
|
PP&E Net
¥39.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-4%
|
|
|
GNI Group Ltd
TSE:2160
|
PP&E Net
¥7.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
26%
|
|
|
PeptiDream Inc
TSE:4587
|
PP&E Net
¥18.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
27%
|
CAGR 10-Years
29%
|
|
|
Takara Bio Inc
TSE:4974
|
PP&E Net
¥62.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
PP&E Net
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ribomic Inc
Glance View
RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 25 full-time employees. The company went IPO on 2014-09-25. Its drug discovery business is divided into self discovery and co-discovery divisions. Self Drug Discovery division develops aptamer and licenses and out the results to pharmaceutical companies. The Co-Discovery division earns the research expenses paid by the alliance partner for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
See Also
What is Ribomic Inc's PP&E Net?
PP&E Net
6m
JPY
Based on the financial report for Dec 31, 2025, Ribomic Inc's PP&E Net amounts to 6m JPY.
What is Ribomic Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
-9%
Over the last year, the PP&E Net growth was 471%. The average annual PP&E Net growth rates for Ribomic Inc have been 125% over the past three years , -31% over the past five years , and -9% over the past ten years .
